Recruiting
Phase 3

DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

Sponsor:

Washington University School of Medicine

Code:

NCT06384573

Conditions

Alzheimer's Disease

Dementia

Alzheimer's Disease, Familial

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

lecanemab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information